CYCLERION THERAPEUTICS, INC. Capital Expenditures Incurred but Not yet Paid
CYCLERION THERAPEUTICS, INC. (CYCN) reported Capital Expenditures Incurred but Not yet Paid of $0 for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-09.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2021-11-09
- CYCLERION THERAPEUTICS, INC. capital expenditures incurred but not yet paid for the quarter ending 2020-09-30 was -$5.00K.
- CYCLERION THERAPEUTICS, INC. capital expenditures incurred but not yet paid for the quarter ending 2020-06-30 was -$30.00K.
- CYCLERION THERAPEUTICS, INC. capital expenditures incurred but not yet paid for the quarter ending 2020-03-31 was $39.00K, a 96.21% decline year-over-year.
- CYCLERION THERAPEUTICS, INC. capital expenditures incurred but not yet paid for the quarter ending 2019-12-31 was $728.00K.
- CYCLERION THERAPEUTICS, INC. capital expenditures incurred but not yet paid for fiscal 2019 was $823.00K, a 80.88% increase from fiscal 2018.
- CYCLERION THERAPEUTICS, INC. capital expenditures incurred but not yet paid for fiscal 2018 was $455.00K.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2021-09-30 | $0.00 10-Q · filed 2021-11-09 | |||
| 2020-09-30 | -$5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$35.00K derived: sum of 2 quarters · filed 2021-11-09 | $4.00K 10-Q · filed 2021-11-09 | $732.00K derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | -$30.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $9.00K 10-Q · filed 2021-07-29 | $737.00K derived: sum of 3 quarters · filed 2021-07-29 | $316.00K derived: sum of 4 quarters · filed 2021-07-29 |
| 2020-03-31 | $39.00K 10-Q · filed 2021-04-30 | $767.00K derived: sum of 2 quarters · filed 2021-04-30 | $346.00K derived: sum of 3 quarters · filed 2021-04-30 | -$167.00K derived: sum of 4 quarters · filed 2021-04-30 |
| 2019-12-31 | $728.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $307.00K derived: sum of 2 quarters · filed 2021-02-25 | -$206.00K derived: sum of 3 quarters · filed 2021-02-25 | $823.00K 10-K · filed 2021-02-25 |
| 2019-09-30 | -$421.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$934.00K derived: sum of 2 quarters · filed 2020-11-05 | $95.00K 10-Q · filed 2020-11-05 | |
| 2019-06-30 | -$513.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-03 | $516.00K 10-Q · filed 2020-08-03 | ||
| 2019-03-31 | $1.03M 10-Q · filed 2020-05-04 | |||
| 2018-12-31 | $455.00K 10-K · filed 2020-03-12 | |||
| 2018-03-31 | $680.00K 10-Q · filed 2019-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |